Interleukin-1 Genotypes Are Predictive of Cardiovascular Events in Patients With Elevated Lipoprotein(a)
Second Study Validates Role in Recurrent Cardiac Events
WALTHAM, MA – March 20, 2017 – Interleukin Genetics, Inc. (OTCQB: ILIU), a life sciences company focused on the genetics of chronic inflammation, announced today the presentation of clinical data from “The Ioannina Study” at the 66th Annual Scientific Session & Expo of the American College of Cardiology (ACC 2017) in Washington, DC that demonstrates the ability of certain interleukin-1 (IL-1) genetic patterns together with elevated lipoprotein (a) (Lp(a)) to predict recurrent atherosclerotic cardiac events. Dr. Bechlioulis and co-workers reported the new findings from the University Hospital of Ioannina (Greece) along with collaborators from the University of California at San Diego.
In the longitudinal study (median time 43 months) of 1,084 patients who […]